Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Size and Demand Forecast 2026–2030
Uncover key drivers, emerging technologies, and competitive movements shaping the messenger ribonucleic acid (mrna) synthesis raw materials market from 2026–2035 with trusted insights from The Business Research Company
What size range is anticipated for the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market from 2026 to 2030?
The messenger ribonucleic acid (mrna) synthesis raw materials market size has seen sustained expansion in recent years. It is anticipated to increase from $3.03 billion in 2025 to $3.12 billion in 2026, at a compound annual growth rate (CAGR) of 3.0%. The expansion observed in the historical period stems from factors such as increasing demand for vaccines, advancements in molecular biology, augmented research and development investments in synthetic biology, the occurrence of infectious disease outbreaks, and the creation of efficient transcription enzymes.
The messenger ribonucleic acid (mrna) synthesis raw materials market size is projected to experience consistent expansion in the coming years. It is anticipated to grow to $3.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.0%. The projected increase over the forecast period is driven by the broadening application of mRNA-based therapeutics, the adoption of automated mRNA synthesis platforms, a rise in personalized medicine initiatives, the expansion of biotechnology manufacturing hubs, and advancements in nucleotide modifications. Significant developments expected during this period include the optimization of synthetic mRNA, the development of high-purity raw materials, the creation of scalable in-vitro transcription processes, the standardization of the supply chain for mRNA production, and robust quality control & regulatory compliance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12336&type=smp
What Drivers Are Affecting Demand In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The increasing incidence of cancer and long-term health conditions is anticipated to drive expansion in the mRNA synthesis raw materials market. Cancer is defined as a disease where abnormal cells proliferate uncontrollably, capable of invading adjacent tissues and potentially disseminating throughout the body via the bloodstream and lymphatic systems. Chronic illnesses are broadly characterized as conditions that persist for a minimum of one year, necessitate continuous medical attention, interfere with daily routines, or both. mRNA synthesis raw materials find application in drug discovery efforts, vaccine development, and the creation of RNA-based therapeutics, providing enhanced immunogenicity, greater efficacy, and quicker production timelines for treating cancer and chronic ailments. For example, in January 2024, data from the American Cancer Society, a US-based non-profit organization, indicated that the United States is projected to experience 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, an increase from 1,958,310 cases and 609,820 deaths in 2023. Furthermore, in September 2025, information from the British Heart Foundation, a UK-based charity, reported that across the UK, more than 7.6 million individuals (over 4 million men and more than 3.6 million women) are living with cardiovascular disease, with forecasts suggesting this number could increase by approximately 1 million by 2030 and by roughly 2 million by 2040, primarily due to an aging population and improved survival rates. Consequently, the rising prevalence of cancer and chronic disorders acts as a significant impetus for mRNA synthesis raw materials.
Which Segment Groups Are Influencing The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
The messenger ribonucleic acid (mrna) synthesis raw materials market covered in this report is segmented –
1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types
2) By Applications: Therapeutics Production, Vaccine Production, Other Applications
3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users
Subsegments:
1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents
2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides
3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA
4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials
Which Competitive Trends Are Impacting The Structure Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Leading entities within the messenger ribonucleic acid (mRNA) synthesis raw materials market are concentrating on forging strategic alliances with the aim of bolstering their technological prowess, broadening their range of superior raw materials, and speeding up the manufacture of advanced mRNA therapeutics. These strategic alliances signify official agreements among biotechnology companies, enzyme manufacturers, and nucleic acid technology specialists, dedicated to jointly creating cutting-edge IVT enzymes, altered nucleotides, capping analogs, or other essential components that contribute to enhanced mRNA yield, greater purity, improved stability, and increased safety. A notable example occurred in September 2024, when TriLink Biotechnologies, a US-based biotechnology firm, partnered with Alphazyme LLC, a US-based company specializing in custom molecular biology enzymes. Their collaboration resulted in the introduction of the CleanScribe RNA Polymerase, an innovative IVT enzyme designed to decrease double-stranded RNA production by as much as 85% during mRNA synthesis, consequently aiding in the creation of safer and more effective mRNA therapeutics.
Who Are The Core Companies Influencing Trends In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market In The Coming Years?
North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in the messenger ribonucleic acid (mrna) synthesis raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12336&type=smp
Browse Through More Reports Similar to the Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
